Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Philips second-quarter earnings beat forecast as pandemic fuels demand

Published 26/07/2021, 06:10
Updated 26/07/2021, 06:40
© Reuters. FILE PHOTO: Logo of Dutch technology company Philips is seen at its company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier/File Photo

© Reuters. FILE PHOTO: Logo of Dutch technology company Philips is seen at its company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier/File Photo

(Reuters) -Dutch health technology company Philips on Monday beat analysts' expectations with a jump in second-quarter core earnings to 532 million euros ($626 million), as the COVID-19 pandemic continued to spur demand for hospital equipment. Analysts polled by the company on average had expected adjusted earnings before interest, taxes and amortisation (EBITA) to rise to 519 million euros in April-June, up from 390 million euros a year earlier.

Philips sells products ranging from toothbrushes to medical imaging systems, and is a main competitor of General Electric (NYSE:GE) and Siemens Healthineers.

Comparable sales increased 9%, beating an average expectation of a 7.3% rise. However, sales in its connected care division fell, dragged lower by its sleep and respiratory care business.

The company booked an additional provision of 250 million euros, following an earlier provision in the first quarter of this year, as it works to repair and replace millions of sleep devices it recalled earlier in June.

Last month, Philips recalled up to 4 million breathing devices and ventilators because of a foam part that might degrade and become toxic, potentially causing cancer.

"We are in discussions with the relevant regulatory authorities to obtain authorisation to start deploying the repair kits and replacement devices that we are producing," Philips Chief Executive Frans van Houten said in a statement.

The U.S. Food and Drug Administration last week classified the recall of Philips' breathing devices and ventilators as the most serious type of recall, saying the use of these devices may cause serious injuries or death.

© Reuters. FILE PHOTO: Logo of Dutch technology company Philips is seen at its company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier/File Photo

The Amsterdam-based company confirmed its forecast of low- to mid-single-digit comparable sales growth for the whole of 2021.

($1 = 0.8492 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.